New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.
about
The role of monoamine oxidase inhibitors in current psychiatric practiceTriple uptake inhibitors: therapeutic potential in depression and beyondDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsImprovement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors.Improvement of the noradrenergic symptom cluster following treatment with milnacipran.
P2860
New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
New approaches to developing a ...... noaminergic neurotransmission.
@ast
New approaches to developing a ...... noaminergic neurotransmission.
@en
type
label
New approaches to developing a ...... noaminergic neurotransmission.
@ast
New approaches to developing a ...... noaminergic neurotransmission.
@en
prefLabel
New approaches to developing a ...... noaminergic neurotransmission.
@ast
New approaches to developing a ...... noaminergic neurotransmission.
@en
P2093
P2860
P1476
New approaches to developing a ...... noaminergic neurotransmission.
@en
P2093
Frank P Bymaster
Pierre V Tran
Robert K McNamara
P2860
P304
P356
10.1517/13543784.12.4.531
P407
P577
2003-04-01T00:00:00Z